Latest Share Chat

REMOVE ADS

Hikma Pharmaceuticals Share News (HIK)

Hikma Pharmaceuticals Information

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes

Get Live Data

1,500.00 -31.00 (-2.02%)

Bid:

1,730.00

Ask:

1,488.00

Spread: -242.00 (-13.988%)

Market Cap: £3.22b

Last checked at -

Intraday Hikma Pharmaceuticals Share Chart

REMOVE ADS

Thursday broker round-up

Thu, 14th Mar 2019 13:22

(Sharecast News) - Savills: Peel Hunt downgrades to hold with a target price of 925p.Ultra Electronics Holdings: Berenberg upgrades to buy with a target price of 1,750p.Greggs: Berenberg reiterates hold with a target price of 1,600p.Quilter: JP Morgan reiterates overweight with a target price of 180p.Entertainment One: JP Morgan reiterates overweight with a target price of 621p.Hikma Pharmaceuticals: JP Morgan reiterates neutral with a target price of 1,700p.On The Beach Group: Citigroup initiates at buy with a target price of 510p.Drax Group: Citigroup reiterates sell with a target price of 312p.Centrica: Citigroup reiterates neutral with a target price of 128p.Cairn Energy: Barclays reiterates overweight with a target price of 245p.Domino's Pizza Group: Barclays reiterates equal weight with a target price of 275p.Sophos Group: Deutsche Bank reiterates hold with a target price of 300p.Morrison: Deutsche Bank reiterates hold with a target price of 235p.Lookers: Liberum reiterates buy with a target price of 126p.Bodycote: RBC Capital Markets reiterates outperform with a target price of 1,000p.Greencoat: RBC Capital Markets reiterates outperform with a target price of 145p.Ferguson: Canaccord reiterates buy with a target price of 5,810p.Capita: Peel Hunt reiterates hold with a target price of 127p.Energean Oil: Peel Hunt initiates buy with a target price of 850p.